The Association Between Weight Loss With Subsequent Maintenance Using Liraglutide and Changes in Skin Autoflouresence in Overweight or Obese Patients With Knee Osteoarthritis - a Substudy to "Effect of Liraglutide on Body Weight and Pain in Overweight or Obese Patients With Knee Osteoarthritis: A Randomised, Double Blind, Placebo-controlled, Parallel Group, Single-centre Trial" (NCT02905864)
Phase of Trial: Phase IV
Latest Information Update: 10 Feb 2017
At a glance
- Drugs Liraglutide (Primary)
- Indications Osteoarthritis
- Focus Pharmacodynamics
- 11 Nov 2016 Status changed from not yet recruiting to recruiting.
- 07 Oct 2016 Planned initiation date changed from 1 Sep 2016 to 1 Oct 2016.
- 29 Sep 2016 New trial record